Solid Biosciences Inc (SLDB) Company Profile & Statistics

Solid Biosciences Inc
SLDB
(Nasdaq - US)
N/A
8.96
-0.34 (-3.66%)
in:usd•As of: May 17, 2024 15:59 UTC -4
Open
9.13
High
9.13
Low
8.82

About Solid Biosciences Inc

CEO

Alexander Cumbo

Headquarters

500 rutherford avenue,third floor

charlestown, ma 02129, united states

Auditor

PricewaterhouseCoopers LLP

Employees

Share Holders

Website

www.solidbio.com

Industry

biotechnology

Sector

health technology

Company Overview

Solid Biosciences LLC is a life science company. It focuses on developing therapies for Duchenne muscular dystrophy. The company is engaged in developing gene therapies, disease modifying therapies and assistive devices, all targeting the various facets of the DMD. Its product candidate includes SGT-001, a gene transfer candidate which is in Phase I/II clinical trial to restore functional dystrophin protein expression in patients' muscles. Solid Biosciences LLC is headquartered in Cambridge, Massachusetts.

Solid Biosciences Inc Statistics

Valuation Measures

Market Capitalization ²	343.88M
Enterprise Value	227.91M
Enterprise Value/EBITDA (ttm)	-2.28
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	1.67
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-55.94%
Return on Invested Capital (ttm)	-56.70%
Return on Assets (ttm)	-44.95%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-99.99M
Net Income Avi to Common (ttm)	-90.25M
Diluted EPS (ttm)	-3.94

Share Statistics

Beta (5Y Monthly)	2.02
52-Week Change	49.33%
S&P500 52-Week Change	26.51%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	38.38M
Dividend Yield	0.00%
Float ⁴	30.54M
% Held by Insiders	19.33%
% Held by Institutions	81.46%

Balance Sheet

Total Cash (mrq)	206.07M
Total Cash Per Share (mrq)	5.37
Total Debt (mrq)	1.60M
Total Debt/Equity (mrq)	0.76%
Current Ratio (mrq)	14.94%
Quick Ratio (mrq)	8.94%
Book Value Per Share (mrq)	5.57

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.66
Free Cash Flow (ytd)	-25.34M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Solid Biosciences Inc

Trade With A Regulated Broker